A Randomized Trial of Unruptured Brain Arteriovenous Malformations Study: What Impact on Clinical Care and Therapeutic Decision?

REFERENCES

1. 1.↵
   2. Mohr JP,
   3. Parides MK,
   4. Stapf C, et al

   ; international ARUBA investigators. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014;383:614–21

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Stapf C,
   3. Mast H,
   4. Sciacca RR, et al

   ; New York Islands AVM Study Collaborators. The New York Islands AVM Study: design, study progress, and initial results. Stroke 2003;34:e29–33

   Abstract/FREE Full Text
3. 3.↵
   2. Stapf C,
   3. Mast H,
   4. Sciacca RR, et al

   . Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 2006;66:1350–55

   CrossRef
4. 4.↵
   2. Stapf C,
   3. Mohr JP,
   4. Choi JH, et al

   . Invasive treatment of unruptured brain arteriovenous malformations is experimental therapy. Curr Opin Neurol 2006;19:63–68

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Raymond J,
   3. Darsaut TE,
   4. Molyneux AJ

   ; TEAM Collaborative Group. A trial on unruptured intracranial aneurysms (the TEAM trial): results, lessons from a failure and the necessity for clinical care trials. Trials 2011;12:64

   CrossRefPubMed
6. 6.↵
   2. Berkhemer OA,
   3. Fransen PS,
   4. Beumer D, et al

   ; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11–20

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Zelen M

   . Randomised consent trials. Lancet 1992;340:375

   PubMed
8. 8.↵
   2. Taylor KM,
   3. Margolese RG,
   4. Soskolne CL

   . Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med 1984;310:1363–70

   CrossRefPubMedWeb of Science